Early Is Good is building diagnostics that see the full biology of cancer — so clinicians and patients can make the right call at the right time.
View Our PipelineEach year, millions of patients must decide whether to biopsy, treat, or monitor. The tests guiding those decisions often measure only one biological signal, missing the full picture of disease.
Dangerous cancers go undetected because current tests lack the sensitivity to catch them early, when treatment matters most.
Patients undergo unnecessary, irreversible procedures — surgeries, biopsies, organ removal — for cancers that never needed aggressive treatment.
Most tests read only one layer of biology. That's like diagnosing an engine by only checking the oil — you miss what's really going on.
Until now, no single platform could analyze DNA, RNA, and Proteins simultaneously from a single sample. Our proprietary technology changes that — delivering a comprehensive multi-omic profile from a simple urine or blood draw.
What mutations are present
What the cancer is actively doing
How the body is responding
Any one alone is an incomplete picture. All three together inform the decisions that matter most: biopsy or wait, treat or monitor, remove an organ or watch.
One platform. Multiple applications. Starting with the cancers where better diagnostics can change the most lives.
We work with world-class clinical partners to validate and bring our tests to patients.
We're looking for scientists, engineers, and operators who want to change the standard of care in cancer diagnostics. Based in Indianapolis.
Sign up for updates on our clinical progress and product availability.
No spam. Unsubscribe anytime.